Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Q1 2026 Earnings Call Transcript

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Q1 2026 Earnings Call Transcript April 30, 2026

Phathom Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.37 EPS, expectations were $-0.17.

Operator: Hello, and welcome to the Phathom Pharmaceuticals First Quarter 2026 Earnings Results Call. [Operator Instructions] Please be advised that today’s call is being recorded. With that, I would like to turn the call over to Eric Sciorilli, Phathom’s Head of Investor Relations....